Tyrosine kinase inhibitor interruptions, discontinuations and switching in patients with chronic‐phase chronic myeloid leukemia in routine clinical practice: SIMPLICITY
暂无分享,去创建一个
J. Cortes | R. Paquette | M. Mauro | S. Gajavelli | C. Gambacorti-Passerini | R. Hehlmann | S. Goldberg | B. Simonsson | T. Zyczynski | L. Williams | M. Michallet | Ginny P. Sen | Irene S. DeGutis | I. DeGutis